Resources
Videos
Pathogen reduction of double dose platelet concentrates from pools of eight Buffy coats: product quality, safety and economic aspects
Pathogen reduction of double dose platelet concentrates from pools of eight Buffy coats: product quality, safety and economic aspects
Economic aspects of introducing pathogen inactivated platelets in treatment cycle of oncology patients in Germany
Economic aspects of introducing pathogen inactivated platelets in treatment cycle of oncology patients in Germany
Economic aspects of introducing pathogen inactivated platelets in treatment cycle of oncology patients in Germany
Economic aspects of introducing pathogen inactivated platelets in treatment cycle of oncology patients in Germany
Economic aspects of introducing pathogen inactivated platelets in treatment cycle of oncology patients in Germany
Transfusing the right product to the right patient
INTERCEPT treated platelets are effective in preventing bleeding
Clinical performance of INTERCEPT and solvent detergent plasma used with idiopathic thrombotic purpura patients requiring therapeutic plasma exchanges
What does published literature tell us about the clinical efficacy of INTERCEPT treated platelets?
Safety surveillance and the introduction of pathogen reduced platelets
No results found.